We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXE icon
12576
NexGen Energy
NXE
$6.97B
$123K ﹤0.01%
30,008
-80,287
-73% -$342K
WKEY
12577
WISeKey
WKEY
$78.8M
$123K ﹤0.01%
3,436
+564
+20% +$24.1K
AGRX
12578
PUT
DELISTED
Agile Therapeutics
AGRX
$123K ﹤0.01%
46
-6
-12% -$19.8K
SIOX
12579
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$123K ﹤0.01%
44,999
+13,307
+42% +$33.1K
FCAX.WS
12580
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$123K ﹤0.01%
113,498
+144
+0.1% +$144
EQOS
12581
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$123K ﹤0.01%
18,848
-8,981
-32% -$62.4K
SWBK.U
12582
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
$123K ﹤0.01%
12,154
-317,184
-96% -$3.24M
YDKG
12583
Yueda Digital Holding
YDKG
$5.92M
$122K ﹤0.01%
105
+18
+21% +$21.9K
AYTU icon
12584
AYTU BioPharma
AYTU
$25.5M
$122K ﹤0.01%
1,219
-19
-2% -$2.23K
OSTRW
12585
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$122K ﹤0.01%
181,323
LFTRU
12586
DELISTED
Lefteris Acquisition Corp. Unit
LFTRU
$122K ﹤0.01%
12,090
-706
-6% -$7.17K
FST
12587
DELISTED
FAST Acquisition Corp.
FST
$122K ﹤0.01%
+10,352
New +$128K
MACK
12588
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$122K ﹤0.01%
19,152
-1,592
-8% -$10.5K
YDKG
12589
CALL
Yueda Digital Holding
YDKG
$5.92M
$121K ﹤0.01%
105
+2
+2% +$2.43K
BQ
12590
PUT
Boqii Holding Ltd
BQ
$8.19M
$121K ﹤0.01%
135
-112
-45% -$105K
LCTX icon
12591
PUT
Lineage Cell Therapeutics
LCTX
$271M
$121K ﹤0.01%
42,600
+3,100
+8% +$8.02K
LXRX icon
12592
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$121K ﹤0.01%
26,400
-29,400
-53% -$142K
RNAC icon
12593
PUT
Cartesian Therapeutics
RNAC
$267M
$121K ﹤0.01%
967
-2,466
-72% -$294K
MARK
12594
CALL
DELISTED
Remark Holdings, Inc.
MARK
$121K ﹤0.01%
6,500
+560
+9% +$10.5K
NIRWW
12595
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$121K ﹤0.01%
156,090
-2,600
-2% -$1.75K
TMPOW
12596
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$121K ﹤0.01%
60,454
-38
-0.1% -$74
KWAC.U
12597
DELISTED
Kingswood Acquisition Corp. Units, each consisting of one share of Class A Common Stock and three-fo
KWAC.U
$121K ﹤0.01%
11,544
-31
-0.3% -$324
RPAI
12598
PUT
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$121K ﹤0.01%
10,600
-7,700
-42% -$90.2K
GLMD icon
12599
Galmed Pharmaceuticals
GLMD
$4.32M
$120K ﹤0.01%
+219
New +$119K
FLZH
12600
Flash Sports & Media Holdings
FLZH
$71.1M
$120K ﹤0.01%
+523
New +$115K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.